NanoString Technologies, Inc. (NASDAQ:NSTG) Director Purchases $201,426.00 in Stock

NanoString Technologies, Inc. (NASDAQ:NSTG – Get Rating) Director William Young bought 35,400 shares of the business’s stock in a transaction on Wednesday, May 24th. The stock was bought at an average price of $5.69 per share, for a total transaction of $201,426.00. Following the completion of the purchase, the director now directly owns 46,700 shares of the company’s stock, valued at approximately $265,723. The transaction was disclosed in a filing with the SEC, which can be accessed through this link.

NanoString Technologies Trading Up 2.4 %

Shares of NSTG opened at $5.58 on Friday. The business’s 50-day moving average price is $8.91 and its 200 day moving average price is $8.88. The stock has a market capitalization of $264.10 million, a P/E ratio of -1.57 and a beta of 1.64. NanoString Technologies, Inc. has a 1-year low of $4.37 and a 1-year high of $18.51. The company has a current ratio of 4.34, a quick ratio of 3.54 and a debt-to-equity ratio of 16.67.

NanoString Technologies (NASDAQ:NSTG – Get Rating) last released its earnings results on Tuesday, February 28th. The biotechnology company reported ($0.95) earnings per share for the quarter, missing the consensus estimate of ($0.61) by ($0.34). NanoString Technologies had a negative net margin of 122.19% and a negative return on equity of 252.96%. The business had revenue of $34.42 million for the quarter, compared to analysts’ expectations of $33.15 million. Analysts expect that NanoString Technologies, Inc. will post -2.31 earnings per share for the current year.

Wall Street Analyst Weigh In

A number of equities research analysts recently weighed in on the stock. StockNews.com assumed coverage on shares of NanoString Technologies in a research note on Thursday, May 18th. They set a “sell” rating on the stock. UBS Group assumed coverage on shares of NanoString Technologies in a research note on Thursday, February 2nd. They set a “buy” rating and a $15.00 price objective on the stock. Finally, Morgan Stanley cut their price objective on shares of NanoString Technologies from $17.00 to $16.00 and set an “equal weight” rating on the stock in a research note on Thursday, March 2nd. One analyst has rated the stock with a sell rating, one has assigned a hold rating and four have assigned a buy rating to the company’s stock. According to data from MarketBeat.com, the company has an average rating of “Moderate Buy” and an average target price of $17.83.

Hedge Funds Weigh In On NanoString Technologies

Institutional investors and hedge funds have recently bought and sold shares of the business. Point72 Middle East FZE purchased a new position in NanoString Technologies during the 4th quarter valued at about $29,000. Natixis acquired a new stake in shares of NanoString Technologies during the 4th quarter valued at about $39,000. Point72 Hong Kong Ltd acquired a new stake in shares of NanoString Technologies during the 2nd quarter valued at about $57,000. Dark Forest Capital Management LP acquired a new stake in shares of NanoString Technologies during the 4th quarter valued at about $66,000. Finally, Tower Research Capital LLC TRC lifted its holdings in shares of NanoString Technologies by 181.5% during the 3rd quarter. Tower Research Capital LLC TRC now owns 5,705 shares of the biotechnology company’s stock valued at $73,000 after buying an additional 3,678 shares during the last quarter.

About NanoString Technologies

(Get Rating)

NanoString Technologies, Inc engages in the development and commercialization of instruments and services for profiling of genes and proteins from tissue sample. It offers the GeoMx Digital Spatial Profiler, nCounter Analysis System product platforms, GeoMx Assays, nCounter Panels & Assays and CosMx Spatial Molecular.